176 related articles for article (PubMed ID: 36366435)
21. Contribution of HN protein length diversity to Newcastle disease virus virulence, replication and biological activities.
Jin J; Zhao J; Ren Y; Zhong Q; Zhang G
Sci Rep; 2016 Nov; 6():36890. PubMed ID: 27833149
[TBL] [Abstract][Full Text] [Related]
22. Identification of a new amino acid mutation in the HN protein of NDV involved in pathogenicity.
Chen X; Jia Y; Wei N; Ye C; Hao H; Xiao S; Wang X; Liu H; Yang Z
Vet Res; 2021 Dec; 52(1):147. PubMed ID: 34930432
[TBL] [Abstract][Full Text] [Related]
23. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
Yang X; Zhou Y; Li J; Fu L; Ji G; Zeng F; Zhou L; Gao W; Wang H
Arch Virol; 2016 May; 161(5):1209-16. PubMed ID: 26873815
[TBL] [Abstract][Full Text] [Related]
24. Two single amino acid substitutions in the intervening region of Newcastle disease virus HN protein attenuate viral replication and pathogenicity.
Liu B; Ji Y; Lin Z; Fu Y; Muhammad Dafallah R; Zhu Q
Sci Rep; 2015 Aug; 5():13038. PubMed ID: 26267791
[TBL] [Abstract][Full Text] [Related]
25. The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect.
Jung BK; An YH; Jang SH; Jang JJ; Kim S; Jeon JH; Kim J; Song JJ; Jang H
Virol J; 2024 Jan; 21(1):7. PubMed ID: 38178138
[TBL] [Abstract][Full Text] [Related]
26. Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein.
Bousse TL; Taylor G; Krishnamurthy S; Portner A; Samal SK; Takimoto T
J Virol; 2004 Dec; 78(23):13351-5. PubMed ID: 15542686
[TBL] [Abstract][Full Text] [Related]
27. Hemagglutinin-neuraminidase gene of genotype VII Newcastle disease virus strains isolated in Japan.
Mase M
J Vet Med Sci; 2022 Jan; 84(1):1-5. PubMed ID: 34789612
[TBL] [Abstract][Full Text] [Related]
28. The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence.
Huang Z; Panda A; Elankumaran S; Govindarajan D; Rockemann DD; Samal SK
J Virol; 2004 Apr; 78(8):4176-84. PubMed ID: 15047833
[TBL] [Abstract][Full Text] [Related]
29. A single amino acid substitution in the haemagglutinin-neuraminidase protein of Newcastle disease virus results in increased fusion promotion and decreased neuraminidase activities without changes in virus pathotype.
Estevez C; King DJ; Luo M; Yu Q
J Gen Virol; 2011 Mar; 92(Pt 3):544-51. PubMed ID: 21123551
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone.
Estevez C; King D; Seal B; Yu Q
Virus Res; 2007 Nov; 129(2):182-90. PubMed ID: 17719672
[TBL] [Abstract][Full Text] [Related]
31. A Y526Q mutation in the Newcastle disease virus HN protein reduces its functional activities and attenuates virus replication and pathogenicity.
Khattar SK; Yan Y; Panda A; Collins PL; Samal SK
J Virol; 2009 Aug; 83(15):7779-82. PubMed ID: 19474107
[TBL] [Abstract][Full Text] [Related]
32. Avian cells expressing the Newcastle disease virus hemagglutinin-neuraminidase protein are resistant to Newcastle disease virus infection.
Morrison TG; McGinnes LW
Virology; 1989 Jul; 171(1):10-7. PubMed ID: 2545025
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
[TBL] [Abstract][Full Text] [Related]
34. Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of newcastle disease virus.
Yan Y; Rout SN; Kim SH; Samal SK
J Virol; 2009 Jun; 83(11):5943-6. PubMed ID: 19321607
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV.
Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR
J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805
[TBL] [Abstract][Full Text] [Related]
36. Recombinant-attenuated
Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
[TBL] [Abstract][Full Text] [Related]
37. Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses.
Kim SH; Subbiah M; Samuel AS; Collins PL; Samal SK
J Virol; 2011 Sep; 85(17):8582-96. PubMed ID: 21680512
[TBL] [Abstract][Full Text] [Related]
38. Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy.
He J; Pan Z; Tian G; Liu X; Liu Y; Guo X; An Y; Song L; Wu H; Cao H; Yu D; Che R; Xu P; Rasoul LM; Li D; Yin J
Virus Res; 2016 Aug; 221():23-9. PubMed ID: 27164362
[TBL] [Abstract][Full Text] [Related]
39. Chicken galectin-1B inhibits Newcastle disease virus adsorption and replication through binding to hemagglutinin-neuraminidase (HN) glycoprotein.
Sun J; Han Z; Qi T; Zhao R; Liu S
J Biol Chem; 2017 Dec; 292(49):20141-20161. PubMed ID: 28978647
[TBL] [Abstract][Full Text] [Related]
40. Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus.
Jin Z; Wei Q; Bi Y; Li Y; Huo N; Mou S; Wang W; Liu H; Yang Z; Chen H; Xiao S
Virol J; 2021 Jan; 18(1):8. PubMed ID: 33407693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
